Omega-3, Metabolic Syndrome, and Schizophrenia: A review

Publish Year: 1396
نوع سند: مقاله ژورنالی
زبان: English
View: 311

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_PSQ-5-1_007

تاریخ نمایه سازی: 16 تیر 1398

Abstract:

According to the literature, schizophrenia is associated with the components of metabolic syndrome. This mental disorder has such manifestations as visceral obesity, impaired lipid metabolism, hyperglycemia, and hypertension. The prevalence rate of schizophrenia varies in different countries. There is a body of evidence about the higher incidence of cardiovascular events in the schizophrenic patients with metabolic syndrome. Therefore, the prevention or treatment of this condition in sthese patients is a matter of fundamental importance. Fish oils, commonly used by people, contain omega-3 fatty acid. Omega-3 has been demonstrated to be effective in the patients with metabolic syndrome. 

Authors

Seyedeh Narjes Roudbaraki

Psychiatry and Behavioral Sciences Research Center, Ibn-e-Sina Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Fatemeh Behdani

Psychiatry and Behavioral Sciences Research Center, Ibn-e-Sina Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Paria Hebrani

Psychiatry and Behavioral Sciences Research Center, Ibn-e-Sina Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Majid Ghayour-Mobarhan

Biochemistry and Nutrition Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.